~~<i id='D2E4532614'><strike id='D2E4532614'><tt id='D2E4532614'><pre id='D2E4532614'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：hotspot 2025-09-28 22:35:49 Page View：2

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： White House finalizes ITC's import ban of latest Apple Watches
Next article： Psychedelics group wrestles with new pharma identity

knowledge

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

Why psychiatrists like me stop taking insurance

Adobe“I’msorry,butI’munabletotakeonnewpatientsatthistime.”I’vesaidthatlinehundredsoftimesinthe15year

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

Feng Zhang, Grail founder join forces on new gene editing startup

ResearcherFengZhang,left,andAlexAravanis,theCEOofMoonwalk.Illustration:ChristineKao/STAT;Photo:Kathe